You are here: Industry Insights > tumour

News List

Antibody-Drug Conjugates – Understanding the "Trojan Horses" Neeta Ratanghayra
May 31, 2021
A robust strategy for targeted therapy, known as antibody-drug conjugates (ADCs), has been developed to counterfeit this challenge.
Structures discovered in brain cancer patients can help fight tumors firstwordpharma
July 07, 2021
Researchers at Uppsala University have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour.
Novel radionuclide therapy found to be more effective in NET patients europeanpharmaceuticalreview
March 24, 2021
The study shows modifying the standard of care for late-stage neuroendocrine tumours (NETs) with Evans blue dye makes the treatment more effective and potentially less toxic.
Novel ionic liquid enables uniform chemotherapy delivery in solid tumours europeanpharmaceuticalreview
February 19, 2021
Co-injecting doxorubicin with LATTE, a novel ionic liquid formulation, resulted in uniform chemotherapy delivery and successful ablation in solid tumours.
CRUK researchers develop new early-stage rectal cancer treatment pharmatimes
December 14, 2020
Cancer Research UK (CRUK) researchers have developed a new treatment for early-stage rectal cancer which they say could provide patients with an improved quality of life.
Immunotherapies could target aggressive pancreatic cancer, research indicates pharmatimes
September 04, 2020
Researchers have discovered that an aggressive form of pancreatic cancer 'hijacks' the immune system's response and therefore is more likely to respond to treatment with immunotherapy, raising hopes for new targets in the fight against the disease.
US approves Roche's new pan-tumour liquid biopsy test pharmatimes
August 28, 2020
US regulators have approved Roche's new pan-tumour liquid biopsy test for patients with solid tumours, offering a potentially more convenient option and an alternative for patients unable to have tissue biopsy.
Intraoperative radiotherapy as effective as external beam radiotherapy, finds study europeanpharmaceuticalreview
August 24, 2020
Researchers reveal that for early breast cancer a single dose of targeted intraoperative radiotherapy (TARGIT-IORT) is as effective at preventing breast cancer recurrence as the standard of care.
Single radiotherapy shot proves effective in breast cancer pharmatimes
August 21, 2020
A breast cancer therapy developed by UCL clinicians which requires just one shot of radiotherapy compared to the weeks-long treatment of current therapies been shown to be effective for most women.
Celleron picks up discarded cancer drug from Roche pharmatimes
August 14, 2020
Oxford, UK-based Celleron Therapeutics has signed a licensing agreement with Roche for exclusive rights to emactuzumab, a monoclonal antibody and tumour microenvironment modulator.

Previous page 1 2 3 4 5 Next page